CDS PM 101

Drug Profile

CDS PM 101

Alternative Names: CDS PM101

Latest Information Update: 10 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator pSivida Inc
  • Class Opioid analgesics
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postoperative pain

Most Recent Events

  • 31 Dec 2008 Discontinued - Phase-I for Postoperative pain in USA (unspecified route)
  • 03 Jan 2006 Control Delivery Systems has been acquired by pSivida
  • 14 Jun 2004 Phase-I clinical trials in Postoperative pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top